KNC Laboratories Co.,Ltd. AI Stock Analysis
Want to see JP:6568 full AI Analyst Report?
KNC Laboratories Co.,Ltd. (6568) AI Stock Analysis
KNC Laboratories Co.,Ltd.
(TSE/TYO:6568)
The stock's primary strength is its attractive valuation, supported by a low P/E ratio and a healthy dividend yield. The financial foundation is stable, but significant margin compression and negative free cash flow are key risks. Technical indicators show a neutral trend, lacking strong bullish or bearish signals, which tempers the overall score.
KNC Laboratories Co.,Ltd. (6568) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 9.77B
- Dividend Yield
- 2.60%
- Average Volume (3M)
- 4,353
- Price to Earnings (P/E)
- 10.1
- Beta (1Y)
- 0.56
- Revenue Growth
- 23.75%
- EPS Growth
- 40.75%
- Country
- Japan
- Employees
- 340
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
KNC Laboratories Co.,Ltd. Business Overview & Revenue Model
Company Description
KNC Laboratories Co., Ltd. engages in research, development, and production solutions for organic chemicals. Its operations are carried out through the following business divisions: Functional Materials Business, Pharmaceutical Business, and Bio Busi...
KNC Laboratories Co.,Ltd. Financial Statement Overview
Summary
The company shows consistent revenue growth and a solid balance sheet with moderate debt. However, profitability margins have compressed significantly, and negative free cash flow due to heavy capex introduces liquidity risk. The overall financial picture is stable but reflects a transitional phase with lower efficiency.
Income Statement
62PositiveBalance Sheet
65PositiveCash Flow
55Neutral| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.09B | 8.18B | 9.15B | 8.63B | 7.44B |
| Gross Profit | 2.39B | 2.27B | 3.24B | 3.26B | 2.06B |
| EBITDA | 2.29B | 1.83B | 3.02B | 3.10B | 1.86B |
| Net Income | 766.20M | 737.33M | 1.49B | 1.54B | 643.46M |
Balance Sheet | |||||
| Total Assets | 21.64B | 20.20B | 18.71B | 15.47B | 14.03B |
| Cash, Cash Equivalents and Short-Term Investments | 2.17B | 2.39B | 3.31B | 2.30B | 1.97B |
| Total Debt | 3.60B | 3.12B | 1.97B | 1.54B | 1.68B |
| Total Liabilities | 7.56B | 6.68B | 5.62B | 3.73B | 3.46B |
| Stockholders Equity | 14.08B | 13.52B | 13.09B | 11.75B | 10.58B |
Cash Flow | |||||
| Free Cash Flow | -363.52M | -1.82B | 850.16M | 863.73M | -248.27M |
| Operating Cash Flow | 2.26B | 1.49B | 3.20B | 1.99B | 585.11M |
| Investing Cash Flow | -2.70B | -3.32B | -2.37B | -1.15B | -613.51M |
| Financing Cash Flow | 222.35M | 909.60M | 178.87M | -523.39M | 39.02M |
KNC Laboratories Co.,Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6568, the sentiment is Positive. The current price of 1268.00 is above the 20-day moving average (MA) of 1237.85, above the 50-day MA of 1236.54, and above the 200-day MA of 1237.62, indicating a bullish trend. The MACD of -1.58 indicates Negative momentum. The RSI at 56.53 is Neutral, neither overbought nor oversold. The STOCH value of 86.17 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6568.
KNC Laboratories Co.,Ltd. Peers Comparison
Overall Rating
JP:436071Outperform
JP:656862Neutral
JP:496051Neutral
JP:453149Neutral
JP:436648Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | JPY 7.88B | 8.38 | ― | 1.64% | 5.56% | ― | |
| 62Neutral | JPY 9.86B | 10.12 | ― | 2.60% | 23.75% | 40.75% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 51Neutral | JPY 7.40B | 19.43 | ― | 1.11% | 6.87% | 300.65% | |
| 49Neutral | JPY 6.90B | 14.18 | ― | 3.16% | 3.90% | -31.32% | |
| 48Neutral | JPY 13.22B | 10.83 | ― | 2.01% | 10.12% | 43.23% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:6568 | KNC Laboratories Co.,Ltd. | 1268.00 | 196.67 | 18.36% | |
| JP:4360 | MANAC Chemical Partners Co.,Ltd | 914.00 | 306.57 | 50.47% | |
| JP:4366 | Daito Chemix Corporation | 399.00 | 139.39 | 53.70% | |
| JP:4531 | Yuki Gosei Kogyo Co., Ltd. | 316.00 | 38.04 | 13.68% | |
| JP:4960 | Chemipro Kasei Kaisya,Ltd. | 456.00 | 141.37 | 44.93% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
